Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1021.

Allelic variants of the human putative peptide transporter involved in antigen processing.

Proc. Natl. Acad. Sci. U.S.A.
Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T.
| May 1, 1992
1022.

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

Proc. Natl. Acad. Sci. U.S.A.
Fruman DA, Klee CB, Bierer BE, Burakoff SJ.
| May 1, 1992
1023.

Nuclear factor of activated T cells contains Fos and Jun.

Nature.
Jain J, McCaffrey PG, Valge-Archer VE, Rao A.
| Apr 30, 1992
1024.

Four models of the physician-patient relationship.

JAMA.
Emanuel EJ, Emanuel LL.
| 4 22, 1992
1027.

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.

N. Engl. J. Med.
Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL.
| Apr 9, 1992
1028.

A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells.

Cell.
Rodewald HR, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL.
| Apr 3, 1992
1029.

Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase.

Proc. Natl. Acad. Sci. U.S.A.
Williams NG, Roberts TM, Li P.
| Apr 1, 1992
1030.

Identification of the integrin VLA-2 as a receptor for echovirus 1.

Science.
Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW.
| Mar 27, 1992
1031.

Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains.

Cell.
Chan BM, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME.
| Mar 20, 1992
1032.

Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.

Proc. Natl. Acad. Sci. U.S.A.
Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R.
| Mar 15, 1992
1033.

A family of beta 7 integrins on human mucosal lymphocytes.

Proc. Natl. Acad. Sci. U.S.A.
Parker CM, Cepek KL, Russell GJ, Shaw SK, Posnett DN, Schwarting R, Brenner MB.
| Mar 1, 1992
1034.

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

Proc. Natl. Acad. Sci. U.S.A.
DeCaprio JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM.
| Mar 1, 1992
1035.

CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.

Proc. Natl. Acad. Sci. U.S.A.
Moingeon P, Lucich JL, McConkey DJ, Letourneur F, Malissen B, Kochan J, Chang HC, Rodewald HR, Reinherz EL.
| Feb 15, 1992
1036.

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.

Nature.
Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R.
| Feb 13, 1992
1037.

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.

Cell.
Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T.
| Jan 10, 1992
1038.

Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.

Science.
Ewen ME, Faha B, Harlow E, Livingston DM.
| Jan 3, 1992
1039.

Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.

Proc. Natl. Acad. Sci. U.S.A.
Latron F, Moots R, Rothbard JB, Garrett TP, Strominger JL, McMichael A.
| Dec 15, 1991
1040.

Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.

Proc. Natl. Acad. Sci. U.S.A.
Sakamoto H, Michaelson J, Jones WK, Bhan AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara JL.
| Dec 1, 1991